STEPHY.T.P, SREEJITH. K, & Dr. BINDU G. (2017). Comparison of quality of life (QOL) for patients with breast Cancer receiving adjuvant tac (docetaxel, doxorubicin, Cyclophosphamide) and fac (5-fluorouracil, doxorubicin, Cyclophosphamide) therapy. International Journal of Pharma and Bio Sciences, 8(3), 373–382. https://doi.org/10.22376/ijpbs.2017.8.3.p373-382